TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Odeum Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
215
|
231 | |
| Financial expenses |
0
|
4 | |
| Earnings before taxes |
-468
|
-341 | |
| EBITDA |
-392
|
-283 | |
| Total assets |
14,183
|
15,256 | |
| Current assets |
10,427
|
11,424 | |
| Current liabilities |
395
|
947 | |
| Equity capital |
13,592
|
13,998 | |
| - share capital |
100
|
100 | |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
95.8%
|
91.8% | |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-217.7%
|
-147.6% | |
| Return on assets (ROA) |
-3.3%
|
-2.2% | |
| Current ratio |
2639.7%
|
1206.3% | |
| Return on equity (ROE) |
-3.4%
|
-2.4% | |
| Change turnover |
-16
|
84 | |
| Change turnover % |
9%
|
-7%
|
57% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % | -100% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.